HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial.

AbstractPURPOSE:
Inulin-type fructans (ITF) are prebiotic dietary fibre (DF) that may confer beneficial health effects, by interacting with the gut microbiota. We have tested the hypothesis that a dietary intervention promoting inulin intake versus placebo influences fecal microbial-derived metabolites and markers related to gut integrity and inflammation in obese patients.
METHODS:
Microbiota (16S rRNA sequencing), long- and short-chain fatty acids (LCFA, SCFA), bile acids, zonulin, and calprotectin were analyzed in fecal samples obtained from obese patients included in a randomized, placebo-controlled trial. Participants received either 16 g/d native inulin (prebiotic n = 12) versus maltodextrin (placebo n = 12), coupled to dietary advice to consume inulin-rich versus inulin-poor vegetables for 3 months, in addition to dietary caloric restriction.
RESULTS:
Both placebo and prebiotic interventions lowered energy and protein intake. A substantial increase in Bifidobacterium was detected after ITF treatment (q = 0.049) supporting our recent data obtained in a larger cohort. Interestingly, fecal calprotectin, a marker of gut inflammation, was reduced upon ITF treatment. Both prebiotic and placebo interventions increased the ratio of tauro-conjugated/free bile acids in feces. Prebiotic treatment did not significantly modify fecal SCFA content but it increased fecal rumenic acid, a conjugated linoleic acid (cis-9, trans-11 CLA) with immunomodulatory properties, that correlated notably to the expansion of Bifidobacterium (p = 0.031; r = 0.052).
CONCLUSIONS:
Our study demonstrates that ITF-prebiotic intake during 3 months decreases a fecal marker of intestinal inflammation in obese patients. Our data point to a potential contribution of microbial lipid-derived metabolites in gastro-intestinal dysfunction related to obesity. CLINICALTRIALS.
GOV IDENTIFIER:
NCT03852069 (February 22, 2019 retrospectively, registered).
AuthorsAudrey M Neyrinck, Julie Rodriguez, Zhengxiao Zhang, Benjamin Seethaler, Cándido Robles Sánchez, Martin Roumain, Sophie Hiel, Laure B Bindels, Patrice D Cani, Nicolas Paquot, Miriam Cnop, Julie-Anne Nazare, Martine Laville, Giulio G Muccioli, Stephan C Bischoff, Jens Walter, Jean-Paul Thissen, Nathalie M Delzenne
JournalEuropean journal of nutrition (Eur J Nutr) Vol. 60 Issue 6 Pg. 3159-3170 (Sep 2021) ISSN: 1436-6215 [Electronic] Germany
PMID33544206 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2021. The Author(s).
Chemical References
  • Dietary Fiber
  • Prebiotics
  • RNA, Ribosomal, 16S
  • Inulin
Topics
  • Dietary Fiber
  • Feces
  • Humans
  • Inflammation
  • Inulin
  • Obesity
  • Prebiotics
  • RNA, Ribosomal, 16S
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: